Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-10-07
1999-11-09
Mertz, Prema
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, 435 691, 435 711, 435 712, 4351723, 4352523, 4353201, C07K 1447, C12N 1512, C12N 1563
Patent
active
059814829
ABSTRACT:
Novel IL-1-R intracellular ligand proteins are disclosed. Polynucleotides encoding the IL-1-R intracellular ligand protein are also disclosed, along with vectors, host cells, and methods of making the IL-1-R intracellular ligand protein. Pharmaceutical compositions containing the IL-1-R intracellular ligand protein, methods of treating inflammatory conditions, and methods of inhibiting IL-1-R intracellular domain binding are also disclosed. Methods of identifying inhibitors of IL-1-R intracellular domain binding and inhibitors identified by such methods are also disclosed.
REFERENCES:
Sambrook et al. (1989) Molecular Cloning A Laboratory Manual, Cold Spring Harbor Laboratory Press, 2.sup.nd edition, pp. 17.2-17.10.
Sorimachi et al. (1990) Biol. Chem. Hoppe-Seylev 371[Suppl.] pp. 171-176.
Imajoh et al., Biochemistry 27:8122-8128 (1988).
Hillier et al., EMBL Database HS7641, Abstract T69976 (1995).
Hillier et al., EMBL Database HS17371, Abstract T54461 (1995).
Hillier et al., EMBL Database HS26829, Abstract T59268 (1995).
Hillier et al., EMBL Database HS22728, Abstract T59227 (1995).
Hillier et al., EMBL Database HS17371, Abstract T98173 (1995).
Emori et al., The Journal of Biological Chemistry261(20):9465-9471 (1986).
DeLuca et al., Biochemica et Biophysica Acta 1216:81-93 (1993).
Sorimachi et al., EMBL Database S10590, Abstract XP002015173.
Horuk et al., Biochem Journal 273(1):79-83 (1991).
McKean et al., Journal of Experimental Medicine 180(4):1321-1328 (1994).
PCT International Application No. PCT/US96/06363.
Graham James
Lin Lih-Ling
Brown Scott A.
Genetics Institute Inc.
Mertz Prema
LandOfFree
Interleukin-1 receptor intracellular ligand proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Interleukin-1 receptor intracellular ligand proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-1 receptor intracellular ligand proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455974